Annals of Nutrition and Metabolism
Original Paper
Regulatory Effect of Sense Line Diet on Cholesterol and Body Weight in Mice Fed a High-Fat DietAn H.-J.a,b · Chung H.-S.a,b · Kim N.-H.b · Hong S.-H.b · Park E.-J.c · Baek S.-H.c · Kim H.-M.aaDepartment of Pharmacology, College of Oriental Medicine, Kyung Hee University, Dongdaemun-Gu, Seoul, bCollege of Pharmacy, Wonkwang University, Iksan, Jeonbuk, and cCollege of Oriental Medicine, Wonkwang University, Iksan, Korea
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Received: December 18, 2003
Accepted: July 15, 2004
Published online: November 30, 2004
Issue release date: November – December
Number of Print Pages: 6
Number of Figures: 4
Number of Tables: 1
ISSN: 0250-6807 (Print)
eISSN: 1421-9697 (Online)
For additional information: https://www.karger.com/ANM
Abstract
Background/Aims: Sense line diet (SLD) is a newly developed dietary functional food that is composed of a lot of herbs. The function of SLD is to help control weight. Although it is reported that each herb has effects on lipid metabolism and obesity, these effects are not the same as SLD. The aim of this study was therefore to investigate whether SLD combined with high fat (HF) diet can influence body weight and fat accumulation. Methods: An experiment was conducted with 40 C57BL/6J mice with an initial body weight of about 16 g. Body weight was recorded every week, plasma levels of triglyceride, low-density lipoprotein (LDL) cholesterol, and high-density lipoprotein (HDL) cholesterol were analyzed at the end of the study. Results: Weight increases in the 10 or 20% SLD group were significantly less than in the HF diet group (p < 0.05). Plasma triglyceride and LDL cholesterol levels were decreased by 52.1 and 34.2% in the 10% SLD group and 15.4 and 15.4% in the 20% SLD group, respectively, compared to the high-fat diet group. HDL cholesterol level was increased by 7.8% in the 10% SLD and by 54.9% in the 20% SLD group. Conclusions: Our findings indicate that SLD may be beneficial in the regulation of high-fat-diet-induced blood circulatory disorders as well as overweight.
© 2004 S. Karger AG, Basel
Related Articles:
References
- Balsiger BM, Murr MM, Poggio JL, Sarr MG: Surgery for weight control in patients with morbid obesity. Med Clin N Am 2000;84:477–489.
- Flatt JP: Diet, lifestyle, and weight maintence. Am J Clin Nutr 1995;62:820–836.
- Oscai LB, Miller WC, Arnall DA: Effects of dietary sugar and of dietary fat on food intake and body fat content in rats. Growth 1987;51:64–73.
- Oscai LB, Brown MM, Miller WC: Effect of dietary fat on food intake, growth and body composition in rats. Growth 1984;48:415–424.
- Barnard RJ, Roberts CK, Varon SM, Berger JJ: Diet-induced insulin resistance precedes other aspects of the metabolic syndrome. J Appl Physiol 1998;84:1311–1315.
- Miller WC, Niederpruem MG, Wallace JP, Lindeman AK: Dietary fat, sugar, and fiber predict body fat content. J Am Diet Assoc 1994;94:612–615.
-
Hill JO, Prentice AM: Sugar and body weight regulation. Am J Clin Nutr 1995;62:264S–273S, Discussion 73S–74S.
- Ghannam N, Kingston M, Al-Meshaal IA, Tariq M, Parman NS, Woodhouse N: The antidiabetic activity of aloes: Preliminary clinical and experimental observations. Horm Res 1986;24:288–294.
- Turnbull WH, Thomas HG: The effect of a Plantago ovata seed containing preparation on appetite variables, nutrient and energy intake. Int J Obes Relat Metab Disord 1995;19:338–342.
- Wu GS, Zhang LY, Okuda H: Inhibitive effect of Umbellatus polyporus polysaccharide on cachexic manifestation induced by toxohormone-L in rats. Zhongguo Zhong Xi Yi Jie He Za Zhi 1997;17:232–233.
- Zbinben S, Seiler CH: Phytotherapy in cardiovascular medicine. Ther Umsch 2002;59:301–306.
- Reynolds T, Dweck AC: Aloe vera leaf gel: A review update. J Ethnopharmacol 1999;68:3–37.
- Dulloo AG, Duret C, Rohrer D, Girardier L, Mensi N, Fathi M, Chantre P, Vandermander J: Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am J Clin Nutr 2000;72:1232–1234.
- Reeves PG, Nielsen FH, Fahey GC: AIN-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition Ad Hoc Writing Committee on the Reformulation of the AIN-76A Rodent Diet. J Nutr 1993;123:1939–1951.
- Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC: Enzymatic determination of total plasma cholesterol. Clin Chem 1974;10:470–475.
- Badham D, Trinder P: An improved color reagent for the determination of blood glucose by the oxidase system. Analyst 1972;97:142–145.
- Pitt B, Mancini G.BJ, Ellis SG, Rosman HS, Park JS, McGovern ME: Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): Reduction in atherosclerosis progression and clinical events. J Am Coll Cardiol 1995;26:1133–1139.
- Friedewald WT, Levy RI, Fredrickson, DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1992;18:499–502.
-
Zec S: Body weight loss with the aid of alginic acid. Med Arthr 1991;45:113–114.
External Resources
- Kao YH, Hiipakka RA, Liao S: Modulation of obesity by a green tea catechin. Am J Clin Nutr 2000;72:1232–1234.
-
Wojcicki J, Samochowiec L, Jaworska M, Hinek A: A research for a model of experimental atherosclerosis: Comparative studies in rabbits, guinea pigs and rats. Pol J Pharmacol 1985;37:11–21.
External Resources
- Sacks FM, Pfeffer M, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JM, Wun CC, Davis BR, Braunwald E: The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996;335:1001–1009.
- Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer A, MacFarlane PW, McKillop JH, Packard CJ, for the West of Scotland Coronary Prevention Study Group: Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995;333:1301–1307.
- Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, Langendorfer A, Stein EA, Kruyer W, Gotto AM: For the AFCAPS/TexCAPS Research Group. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. JAMA 1998;279:1615–1622.
- Gordon T, Castelli WP, Hjortland MC, Kannel, WB, Dawber TR: High density lipoprotein as a protective factor against coronary heart disease: The Framingham study. Am J Med 1997;62:707–714.
- Miller NE, Forde OH, Thelle DS, Mjos OD: The Tromso Heart Study: High-density lipoprotein as a protective factor against coronary heart disease: A prospective case-control study. Lancet 1977;i:965–967.
- Gordon DJ, Rifkind BM: High density lipoprotein: The clinical implications of recent studies. N Engl J Med 1989;321:1311–1316.
-
Reichl D, Miller NE: Pathophysiology of reverse cholesterol transport. Insight from inherited disorders of lipoprotein metabolism. Arterioscl Throm Vas 1989;9:785–797.
External Resources
- Durrington PN: How HDL protects against atheroma. Lancet 1993;342:1315–1316.
- Mary NK, Shylesh BS, Babu BH, Padikkala J: Antioxidant and hypolipidaemic activity of a herbal formulation liposem. Indian J Exp Biol 2002;40:901–904.
- Talpur NA, Echard BW, Manohar V, Preuss HG: Influence of a combination of herbs on appetite suppression and weight loss in rats. Diabetes Obes Metab 2001;3:181–185.
Article / Publication Details
Received: December 18, 2003
Accepted: July 15, 2004
Published online: November 30, 2004
Issue release date: November – December
Number of Print Pages: 6
Number of Figures: 4
Number of Tables: 1
ISSN: 0250-6807 (Print)
eISSN: 1421-9697 (Online)
For additional information: https://www.karger.com/ANM
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Get Permission